UNSPSC 51412014: Linsidomine hydrochloride

This classification denotes a vasodilating agent and nitric oxide-releasing compound with the molecular formula C6H10N4O2.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y0054U597M. European Medicines Agency schedules linsidomine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21667. The term linsidomine hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule linsidomine hydrochloride under HS 29349990 and SITC 51579.

As of Q4 2014, LINSIDOMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1C(ON[N+]1N2CCOCC2)N.[CL-].

UNSPSC 51412014 Linsidomine hydrochloride is a Commodity code covering pharmaceutical products for emergency medical use, though recent state and local activity shows the code being applied to broader advanced life support medication procurement rather than linsidomine specifically. State and local governments buy under this code primarily to stock emergency medical supplies — particularly injectables for cardiac and respiratory interventions — for fire departments, emergency medical services, and hospital systems. The issuing bodies soliciting under the code include municipal purchasing departments and fire rescue authorities within metropolitan areas. Procurement typically takes the form of sealed bids for fixed quantities of specific medications with firm pricing, FOB delivery, and strict shelf-life requirements; vendors must warrant product quality and manage expiration-date replacement as part of contract performance.

The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026, and an estimated contract value of $40,000. The solicitation called for four specific medication line items including labetalol, epinephrine, adenosine, and diltiazem vials, with nine-month minimum shelf life and ten-calendar-day delivery windows; the contract term is one year with two optional one-year renewals plus three possible 30-day extensions. Tampa designated the opportunity as a Small Local Business Enterprise sheltered market with a 5 percent bid discount capped at $10,000 for SLBE participation. The source does not identify other recent opportunities under this code or geographic spread beyond Florida.